Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,929 | -60,542 | -46,090 | 5,025 | 37,571 |
| Depreciation Amortization | 7,041 | 4,619 | 3,514 | 3,792 | 3,035 |
| Accounts receivable | N/A | -1,671 | 13,528 | -12,878 | 2,813 |
| Other Working Capital | 8,703 | 1,609 | 12,097 | -13,671 | -4,082 |
| Other Operating Activity | 35,188 | 8,845 | -12,656 | -17,562 | -40,035 |
| Operating Cash Flow | $-37,997 | $-47,140 | $-29,607 | $-35,294 | $-698 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -193,929 | -103,411 | 5,953 | -33,793 | -4,823 |
| PPE Investments | -1,925 | -1,567 | -505 | -939 | -505 |
| Other Investing Activity | 40 | -388 | -108 | -29 | 1,796 |
| Investing Cash Flow | $-195,814 | $-105,366 | $5,340 | $-34,761 | $-3,532 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 276,992 | 138,731 | 5,302 | 83,702 | 286 |
| Financing Cash Flow | $276,992 | $138,731 | $5,302 | $83,702 | $286 |
| Beginning Cash Position | 31,014 | 44,789 | 63,754 | 50,107 | 54,051 |
| End Cash Position | 74,195 | 31,014 | 44,789 | 63,754 | 50,107 |
| Net Cash Flow | $43,181 | $-13,775 | $-18,965 | $13,647 | $-3,944 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,997 | -47,140 | -29,607 | -35,294 | -698 |
| Capital Expenditure | -1,934 | -1,612 | -545 | -971 | -750 |
| Free Cash Flow | -39,931 | -48,752 | -30,152 | -36,265 | -1,448 |